Moleculin Biotech, Inc. (MBRX) Financials
MBRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 39.5 million | 4.4 million |
2023-06-30 | 47.1 million | 6.8 million |
2023-03-31 | 51.1 million | 5.4 million |
2022-12-31 | 57.4 million | 5.2 million |
MBRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -7.6 million | 493000 |
2023-06-30 | -5.1 million | 513000 |
2023-03-31 | -6.0 million | 499000 |
2022-12-31 | -7.3 million | 535000 |
MBRX Net Income
No data available :(
MBRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 24.6 million | - | 496000 |
2023-06-30 | 32.2 million | - | 291000 |
2023-03-31 | 37.3 million | - | 308000 |
2022-12-31 | 43.1 million | - | 451000 |
MBRX Shares Outstanding
MBRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 28000 | 3.3 million | 2.6 million | - |
2023-06-30 | 15000 | 3.9 million | 2.5 million | - |
2023-03-31 | 15000 | 5.7 million | 2.7 million | - |
2022-12-31 | 67000 | 4.2 million | 2.8 million | - |
MBRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 32000 |
2023-06-30 | - | 31000 |
2023-03-31 | - | 140000 |
2022-12-31 | - | 28000 |
MBRX
Price: $5.02
52 week price:
Earnings Per Share: -15.15 USD
P/E Ratio: -0.56
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 14187
Ebitda: -2.9 millionMarket Capitalization: 11.8 million